Get started
Author

Alemayehu Lelisa Duga

Observed names: A. Duga, Alemayehu Duga, Alemayehu Duga Duga, Alemayehu L. Duga, Alermayehu Lelisa Duga, Duga, Alemayehu, Duga, Alemayehu Lelisa
Observed institutions: Université de Bordeaux, Baylor College of Medicine, Texila American University, Istituti Clinici Scientifici Maugeri, Baylor College of Medicine Children’s Foundation, Africa Centres for Disease Control and Prevention, Bordeaux Population Health, African Union, Children’s Foundation, Ministry of Health
ORCID: 0000-0003-3944-1025
Observed ORCID: 0000-0003-3944-1025
OpenAlex ID: A5078916286
Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
2021 · S. Koirala, S. Borisov, et al. · Pulmonology · 50
PDF
Strengthening National Regulatory Authorities in Africa: A Critical Step Towards Enhancing Local Manufacturing of Vaccines and Health Products
2025 · Alemayehu Duga, Nebiyu Dereje, et al. · Vaccines · 18
PDF
An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini
2022 · Alemayehu L. Duga, Sibongile Magongo, et al. · AIDS Research and Therapy · 12
PDF
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase®)
2023 · Alemayehu Lelisa Duga, Francesco Salvo, et al. · Antibiotics · 11
PDF
Baseline assessment of pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis
2021 · Everdina W. Tiemersma, Ibrahim Ali, et al. · BMC Health Services Research · 8
PDF
Resurgence of malaria and artemisinin resistance in Africa requires a concerted response
2025 · Nebiyu Dereje, Mosoka Papa Fallah, et al. · Nature Medicine · 6
Development, assessment and educational impact of a blended e-learning training program on pharmacovigilance implemented in four African countries
2024 · Francesco Schievano, Kissa W. Mwamwitwa, et al. · Frontiers in Medicine · 5
PDF
A community engagement framework to accelerate the uptake of malaria vaccines in Africa
2024 · Nebiyu Dereje, Mosoka Papa Fallah, et al. · Nature Medicine · 3
Evaluation of Co-trimoxazole as Preventive Therapy for People Living With Hiv/aids in Jimma Health Center, Southwest Ethiopia
2014 · Gizat Molla Kassie, Alemayehu Lelisa Duga, et al. · International Research Journal of Pharmacy · 3
PDF
Diethylene glycol: Unnoticed threat in the landscape of fixed-dose combination medications
2025 · Alemayehu L. Duga, Mosoka P. Fallah, et al. · Journal of Public Health in Africa · 2
PDF
Baseline assessment of Pharmacovigilance activities in four sub-Saharan African countries: a perspective on tuberculosis
2021 · Everdina W. Tiemersma, Ali Ibrahim, et al. · Research Square · 2
PDF
Comparative Study of the Effects of Antiretroviral Therapy (art) on Cd4 Cell Count in Jimma University Specialized Hospital, Jimma Town, Oromia Region, Ethiopia
2014 · Alemayehu Lelisa Duga, Gizat Molla Kassie, et al. · Journal of Pharmaceutical and Scientific Innovation · 2
Data on Strengthening Pharmacovigilance Systems through Africa–Europe Collaboration: Insights from a Regulatory Roundtable Discussion
2026 · Mbanya, Vivian Nchanchou, de Jong, Amos, et al. · Zenodo (CERN European Organization for Nuclear Research) · 1
Malaria vaccine rollout begins in Africa: the need to strengthen regulatory and safety surveillance systems in Africa
2024 · Alemayehu Lelisa Duga, Ngashi Ngongo, et al. · BMJ Global Health · 1
PDF
Eswatini’s formidable task of fighting against COVID-19
2021 · Mutale Diluxe, Alemayehu Lelisa Duga, et al. · Razi International Medical Journal · 1
PDF
Acute kidney Injury: Prevalence, Diagnosis, Causes and treatment
2016 · Alermayehu Lelisa Duga · TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH · 1
PDF
Assessing consequences of maternal immunization on fetal outcomes - A meeting report
2026 · Stephen Evans, Flor M. Munoz, et al. · Biologicals
Adverse events following immunization during COVID-19 mass vaccination campaigns in the Democratic Republic of Congo: Findings from active safety surveillance
2026 · Kizito Kayumba, Alemayehu Duga Duga, et al. · PLoS ONE
PDF
Inspiring, shaping and sustaining an African research & development agenda
2026 · Mosoka P. Fallah, Misaki Wayengera, et al. · Nature Medicine
PDF
Barriers and Facilitators of Signal Detection in African Pharmacovigilance Centres: Insights from a Multi-Country Qualitative Study
2026 · Alemayehu Duga, Mulugeta Russom, et al. · SSRN Electronic Journal
Patterns of adverse drug reactions in patients with drug resistant tuberculosis in Eswatini : a retrospective cohort study
2024 · Duga, Alemayehu Lelisa · HAL (Le Centre pour la Communication Scientifique Directe)
PDF
Patterns of adverse drug reactions in patients with drug resistant tuberculosis in Eswatini : a retrospective cohort study
2024 · Alemayehu Lelisa Duga
Works count: 22
Citation count: 126
H-index: 6
I10-index: 4
Year
Topic
Type